Posters
- Home
- Education Events
- Posters
- Validation of a FVIII Chromogenic Nijmegen Bethesda Assay for the Detection of Inhibitors in the Presence of Emicizumab (ACE-910)
Validation of a FVIII Chromogenic Nijmegen Bethesda Assay for the Detection of Inhibitors in the Presence of Emicizumab (ACE-910)
03 Oct 2019
Published in: NHF Bleeding Disorders Conference (National Hemophilia Foundation)
Authors:
- Stefan Tiefenbacher
- Shrotriya S
- Robinson MM
- Adamkewicz J
- Steinbuesch D